CIAO2B
gene geneOn this page
Also known as CGI-128MIP18CIA2B
Summary
CIAO2B (cytosolic iron-sulfur assembly component 2B, HGNC:24261) is a protein-coding gene on chromosome 16q22.1, encoding Cytosolic iron-sulfur assembly component 2B (Q9Y3D0). Component of the cytosolic iron-sulfur protein assembly (CIA) complex, a multiprotein complex that mediates the incorporation of iron-sulfur cluster into extramitochondrial Fe/S proteins. It is a common-essential gene (DepMap: required in 97.4% of cancer cell lines).
Involved in chromosome segregation and protein maturation. Located in cytosol; nucleoplasm; and spindle. Part of MMXD complex and cytosolic [4Fe-4S] assembly targeting complex.
Source: NCBI Gene 51647 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- Clinical variants (ClinVar): 35 total
- GTEx eGene: eQTL in 6 tissues, sQTL in 0 (q < 0.05)
- Cancer dependency (DepMap): dependent in 97.4% of screened cell lines (common-essential)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.68 (unconstrained)
- MANE Select transcript:
NM_016062
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24261 |
| Approved symbol | CIAO2B |
| Name | cytosolic iron-sulfur assembly component 2B |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-128, MIP18, CIA2B |
| Ensembl gene | ENSG00000166595 |
| Ensembl biotype | protein_coding |
| OMIM | 614778 |
| Entrez | 51647 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 9 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay
MANE Select: ENST00000422424
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 2, TSL 3: 1, TSL 5: 2
ENST00000422424, ENST00000562362, ENST00000563490, ENST00000567511, ENST00000568572, ENST00000569299, ENST00001088370, ENST00001093019, ENST00001115439, ENST00001115440, ENST00001126228, ENST00001136950
RefSeq mRNA: 1 — MANE Select: NM_016062
NM_016062
CCDS: CCDS45506
Canonical transcript exons
ENST00000422424 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001621441 | 66933987 | 66934066 |
| ENSE00001665391 | 66932065 | 66932300 |
| ENSE00001687555 | 66934223 | 66934402 |
| ENSE00003479677 | 66932780 | 66932825 |
| ENSE00003647556 | 66933614 | 66933739 |
Expression profiles
Bgee: expression breadth ubiquitous, 285 present calls, max score 99.07.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 83.4264 / max 229.1838, expressed in 1827 samples.
Highest expression (Bgee): lower esophagus mucosa, gastrocnemius, hindlimb stylopod muscle, C1 segment of cervical spinal cord, adenohypophysis.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CIAO2B is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 6 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
6 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Esophagus Mucosa | eqtl | 3.1e-19 | -0.30 | 16:66900250:T:C |
| Testis | eqtl | 3.5e-03 | -0.38 | 16:67201353:A:G |
| Skin Sun Exposed Lower leg | eqtl | 2.1e-02 | -0.21 | 16:67849291:G:A |
| Breast Mammary Tissue | eqtl | 3.1e-02 | -0.30 | 16:66350252:TA:T |
| Esophagus Gastroesophageal Junction | eqtl | 3.3e-02 | +0.30 | 16:67664019:C:T |
| Esophagus Muscularis | eqtl | 4.1e-02 | +0.32 | 16:67077227:G:A |
FANTOM5 promoters
3 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157733 | 80.7492 | 1826 |
| 157734 | 1.9012 | 1341 |
| 157732 | 0.7761 | 390 |
Top tissues by expression
showing 100 of 288 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 99.07 | gold quality |
| gastrocnemius | UBERON:0001388 | 98.77 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 98.63 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 98.58 | gold quality |
| adenohypophysis | UBERON:0002196 | 98.42 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 98.36 | gold quality |
| spinal cord | UBERON:0002240 | 98.29 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 98.25 | gold quality |
| muscle of leg | UBERON:0001383 | 98.18 | gold quality |
| heart left ventricle | UBERON:0002084 | 98.15 | gold quality |
| apex of heart | UBERON:0002098 | 98.13 | gold quality |
| cardiac ventricle | UBERON:0002082 | 98.10 | gold quality |
| pituitary gland | UBERON:0000007 | 98.06 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 98.06 | gold quality |
| left adrenal gland | UBERON:0001234 | 98.02 | gold quality |
| right atrium auricular region | UBERON:0006631 | 98.00 | gold quality |
| right adrenal gland | UBERON:0001233 | 97.94 | gold quality |
| esophagus mucosa | UBERON:0002469 | 97.90 | gold quality |
| prefrontal cortex | UBERON:0000451 | 97.89 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.87 | gold quality |
| amygdala | UBERON:0001876 | 97.86 | gold quality |
| oocyte | CL:0000023 | 97.85 | gold quality |
| muscle organ | UBERON:0001630 | 97.85 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.84 | gold quality |
| cingulate cortex | UBERON:0003027 | 97.84 | gold quality |
| adrenal cortex | UBERON:0001235 | 97.83 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 97.83 | gold quality |
| nucleus accumbens | UBERON:0001882 | 97.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 97.75 | gold quality |
| left coronary artery | UBERON:0001626 | 97.73 | gold quality |
| metanephros cortex | UBERON:0010533 | 97.68 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 97.68 | gold quality |
| stromal cell of endometrium | CL:0002255 | 97.67 | gold quality |
| esophagus | UBERON:0001043 | 97.63 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 97.63 | gold quality |
| lower esophagus | UBERON:0013473 | 97.63 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 97.63 | gold quality |
| cerebellar cortex | UBERON:0002129 | 97.62 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 97.62 | gold quality |
| heart | UBERON:0000948 | 97.57 | gold quality |
| heart right ventricle | UBERON:0002080 | 97.54 | gold quality |
| left ovary | UBERON:0002119 | 97.54 | gold quality |
| adult organism | UBERON:0007023 | 97.54 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 97.54 | gold quality |
| tibialis anterior | UBERON:0001385 | 97.53 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.53 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 97.52 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 97.51 | gold quality |
| ascending aorta | UBERON:0001496 | 97.48 | gold quality |
| thoracic aorta | UBERON:0001515 | 97.48 | gold quality |
| coronary artery | UBERON:0001621 | 97.48 | gold quality |
| popliteal artery | UBERON:0002250 | 97.48 | gold quality |
| tibial artery | UBERON:0007610 | 97.47 | gold quality |
| aorta | UBERON:0000947 | 97.45 | gold quality |
| biceps brachii | UBERON:0001507 | 97.45 | gold quality |
| putamen | UBERON:0001874 | 97.45 | gold quality |
| tibial nerve | UBERON:0001323 | 97.42 | gold quality |
| triceps brachii | UBERON:0001509 | 97.42 | gold quality |
| right ovary | UBERON:0002118 | 97.39 | gold quality |
| left uterine tube | UBERON:0001303 | 97.38 | gold quality |
| cerebellum | UBERON:0002037 | 97.35 | gold quality |
| body of tongue | UBERON:0011876 | 97.34 | gold quality |
| endocervix | UBERON:0000458 | 97.33 | gold quality |
| right coronary artery | UBERON:0001625 | 97.33 | gold quality |
| cardiac atrium | UBERON:0002081 | 97.32 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 97.32 | gold quality |
| right testis | UBERON:0004534 | 97.26 | gold quality |
| transverse colon | UBERON:0001157 | 97.24 | gold quality |
| deltoid | UBERON:0001476 | 97.24 | gold quality |
| right lung | UBERON:0002167 | 97.24 | gold quality |
| ectocervix | UBERON:0012249 | 97.24 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 97.23 | gold quality |
| left testis | UBERON:0004533 | 97.22 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 97.22 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 97.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 97.17 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 97.15 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 97.13 | gold quality |
| right lobe of liver | UBERON:0001114 | 97.08 | gold quality |
| hypothalamus | UBERON:0001898 | 97.08 | gold quality |
| body of uterus | UBERON:0009853 | 97.07 | gold quality |
| peritoneum | UBERON:0002358 | 97.05 | gold quality |
| omental fat pad | UBERON:0010414 | 97.05 | gold quality |
| granulocyte | CL:0000094 | 97.04 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 97.03 | gold quality |
| upper lobe of lung | UBERON:0008948 | 97.00 | gold quality |
| body of stomach | UBERON:0001161 | 96.96 | gold quality |
| ventricular zone | UBERON:0003053 | 96.92 | gold quality |
| mucosa of stomach | UBERON:0001199 | 96.90 | gold quality |
| gluteal muscle | UBERON:0002000 | 96.90 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 96.90 | gold quality |
| neocortex | UBERON:0001950 | 96.88 | gold quality |
| adrenal gland | UBERON:0002369 | 96.88 | gold quality |
| cortical plate | UBERON:0005343 | 96.88 | gold quality |
| thyroid gland | UBERON:0002046 | 96.87 | gold quality |
| frontal cortex | UBERON:0001870 | 96.83 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 96.80 | gold quality |
| colon | UBERON:0001155 | 96.76 | gold quality |
| forebrain | UBERON:0001890 | 96.73 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 96.67 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 14.42 |
| E-MTAB-8142 | yes | 10.81 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 80 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Skeletal muscle | tissue | 228.8 | medium |
| Heart muscle | tissue | 126.4 | medium |
| Tongue | tissue | 111.8 | |
| Pituitary gland | tissue | 108.0 | |
| Parathyroid gland | tissue | 107.8 | low |
| Esophagus | tissue | 97.0 | medium |
| Liver | tissue | 86.4 | low |
| Vagina | tissue | 81.0 | medium |
| Locus coeruleus | tissue | 80.6 | |
| Lymph node | tissue | 78.1 | medium |
| Spinal cord | tissue | 77.8 | |
| Putamen | tissue | 75.8 | |
| Nucleus accumbens | tissue | 75.2 | |
| Kidney | tissue | 74.2 | medium |
| Adrenal gland | tissue | 73.8 | medium |
| Hippocampus | tissue | 73.6 | medium |
| Septum | tissue | 71.8 | |
| Pons | tissue | 71.6 | |
| Medulla oblongata | tissue | 71.1 | |
| Corpus callosum | tissue | 70.9 | |
| Ovary | tissue | 70.1 | low |
| Basal ganglia | tissue | 69.6 | medium |
| Thyroid gland | tissue | 69.2 | low |
| Midbrain | tissue | 69.0 | |
| Choroid plexus | tissue | 68.7 | |
| Hippocampal formation | tissue | 68.4 | |
| Postcentral gyrus | tissue | 66.5 | |
| Colon | tissue | 65.9 | medium |
| Ventral forebrain | tissue | 65.7 | |
| Urinary bladder | tissue | 65.4 | medium |
| Thymus | tissue | 65.1 | |
| Substantia nigra | tissue | 64.6 | |
| Small intestine | tissue | 63.7 | medium |
| Thalamus | tissue | 63.4 | |
| Fallopian tube | tissue | 62.1 | medium |
| Placenta | tissue | 62.0 | medium |
| Superior colliculi | tissue | 60.8 | |
| Cerebral cortex | tissue | 60.6 | medium |
| Somatosensory cortex | tissue | 60.6 | |
| Hypothalamus | tissue | 59.4 | |
| Duodenum | tissue | 59.4 | low |
| Tonsil | tissue | 59.2 | medium |
| Epididymis | tissue | 58.9 | medium |
| Occipital cortex | tissue | 56.3 | |
| Stomach 1 | tissue | 56.2 | medium |
| Rectum | tissue | 56.1 | medium |
| Spleen | tissue | 56.0 | medium |
| Appendix | tissue | 55.8 | medium |
| Pancreas | tissue | 55.7 | medium |
| Periaqueductal gray | tissue | 55.1 | |
| Gallbladder | tissue | 54.2 | low |
| Motor cortex | tissue | 53.1 | |
| Entorhinal cortex | tissue | 53.1 | |
| Lung | tissue | 52.5 | medium |
| Prefrontal cortex | tissue | 52.3 | |
| Temporal cortex | tissue | 52.1 | |
| Adipose tissue | tissue | 51.2 | medium |
| Retrosplenial and cingulate cortex | tissue | 50.0 | |
| Salivary gland | tissue | 49.8 | low |
| Smooth muscle | tissue | 49.3 | medium |
Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — Lateral funiculus (white matter) (112.2), Cerebellar nuclei (110.0), Dorsal funiculus (white matter) (109.1), Cerebellar white matter (106.8), Anterior funiculus (white matter) (105.4).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting CIAO2B by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
16 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-556-3P | 99.74 | 68.75 | 1203 |
| HSA-MIR-4427 | 99.34 | 70.33 | 1854 |
| HSA-MIR-520E-5P | 99.27 | 68.90 | 1513 |
| HSA-MIR-10399-5P | 99.17 | 69.87 | 2610 |
| HSA-MIR-6504-3P | 99.17 | 69.31 | 2891 |
| HSA-MIR-4289 | 98.26 | 66.90 | 810 |
| HSA-MIR-4471 | 95.11 | 66.84 | 755 |
| HSA-MIR-8059 | 95.11 | 66.30 | 646 |
| HSA-MIR-4765 | 93.11 | 66.17 | 737 |
Functional genomics
gnomAD constraint: pLI 1.99e-08, LOEUF 1.68, missense Z 0.0557 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000422424 — one region, missense o/e 0.97.
DepMap (CRISPR cell-line fitness): dependent in 97.4% of screened cell lines, common-essential.
Most-dependent cell lines (DepMap gene-effect, lower = stronger; ≤ −0.5 shown): KP-N-YN (-2.344), LS1034 (-2.298), OUMS-23 (-2.205), OCUM-1 (-2.128), SK-N-FI (-2.071), SCC-25 (-2.056), KALS-1 (-2.056), SUP-M2 (-1.889), RCC10RGB (-1.85), NCI-H2052 (-1.845), SNU-1033 (-1.845), CL-11 (-1.844), OV-90 (-1.827), SNU-840 (-1.796), HCC-827 (-1.79).
Literature-anchored findings (GeneRIF, showing 9)
- these findings suggest that FAM96B acts as a regulator of E2-2 through the control of its protein expression. (PMID:21722264)
- The mammalian proteins MMS19, MIP18, and ANT2 are involved in cytoplasmic iron-sulfur cluster protein assembly. (PMID:23150669)
- CIA2B-CIA1-MMS19 and CIA2A-CIA1 assist different branches of Fe/S protein assembly and intimately link this process to cellular iron regulation via IRP1 Fe/S cluster maturation and IRP2 stabilization. (PMID:23891004)
- Co-localization experiments by fluorescent confocal microscopy revealed that FAM96B colocalized with prelamin A in HEK-293 cells. (PMID:24041693)
- Data suggest that CIA2B and MMS19 physically interact with C-terminus of viperin/RSAD2; CIAO1 appears to function as primary viperin-interacting protein; CIA2A binds to N-terminus of viperin in CIAO1-, CIA2B-, and MMS19-independent fashion. (CIA2B = metallochaperone CIA2B/FAM96B; MMS19 = transcription factor MMS19; CIAO1 = cytosolic iron-sulfur assembly component 1; CIA2A = metallochaperone CIA2A/Fam96a) (PMID:28615450)
- We performed a yeast two-hybrid screen on a human fetal brain cDNA library and identified FAM96B as a novel binding partner of SelW. FRET analyses confirmed the interaction between SelW’ and FAM96B. (PMID:30876693)
- FAM96B inhibits the senescence of dental pulp stem cells. (PMID:32039527)
- Structural insights into Fe-S protein biogenesis by the CIA targeting complex. (PMID:32632277)
- Fam96b recruits brain-type creatine kinase to fuel mitotic spindle formation. (PMID:36503010)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ciao2b | ENSDARG00000052010 |
| mus_musculus | Ciao2b | ENSMUSG00000031879 |
| rattus_norvegicus | Ciao2b | ENSRNOG00000011865 |
| drosophila_melanogaster | galla-2 | FBGN0036107 |
| caenorhabditis_elegans | WBGENE00009736 |
Paralogs (1): CIAO2A (ENSG00000166797)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1915773) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 10 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| increased neutrophil cell number | 1 |
| abnormal heart morphology | 1 |
| enlarged heart | 1 |
| abnormal spleen morphology | 1 |
| enlarged spleen | 1 |
| abnormal skin morphology | 1 |
| increased spleen weight | 1 |
| preweaning lethality, complete penetrance | 1 |
| embryonic lethality prior to organogenesis | 1 |
| embryonic lethality prior to tooth bud stage | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q3T0U7 | 96.9% | Diamond |
| Schizosaccharomyces pombe 972h- | Q9UTL0 | 61.2% | Diamond |
| Dictyostelium discoideum | Q54QK1 | 60.9% | Diamond |
| Arabidopsis thaliana | Q9C9G6 | 60.5% | Diamond |
| Saccharomyces cerevisiae S288C | P38829 | 55.5% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| RRAD | protein-coding | 6236 |
| CES3 | protein-coding | 23491 |
| CES4A | protein-coding | 283848 |
| CES2 | protein-coding | 8824 |
| CDH16 | protein-coding | 1014 |
Protein
Protein identifiers
Cytosolic iron-sulfur assembly component 2B — Q9Y3D0 (reviewed: Q9Y3D0)
Alternative names: MSS19-interacting protein of 18 kDa, Mitotic spindle-associated MMXD complex subunit MIP18, Protein FAM96B
All UniProt accessions (4): Q9Y3D0, H3BNV7, J3KS95, J3QLT9
UniProt curated annotations — full annotation on UniProt →
Function. Component of the cytosolic iron-sulfur protein assembly (CIA) complex, a multiprotein complex that mediates the incorporation of iron-sulfur cluster into extramitochondrial Fe/S proteins. As a CIA complex component and in collaboration with CIAO1 and MMS19, binds to and facilitates the assembly of most cytosolic-nuclear Fe/S proteins. As part of the mitotic spindle-associated MMXD complex it plays a role in chromosome segregation, probably by facilitating iron-sulfur cluster assembly into ERCC2/XPD. Together with MMS19, facilitates the transfer of Fe-S clusters to the motor protein KIF4A, which ensures proper localization of KIF4A to mitotic machinery components to promote the progression of mitosis.
Subunit / interactions. Component of the CIA complex. Component of the MMXD complex, which includes CIAO1, ERCC2, CIAO2B, MMS19 and SLC25A5. Interacts with CIAO1, ERCC2 and MMS19; the interactions are direct. Interacts with KIF4A; the interaction facilitates the transfer of Fe-S clusters to KIF4A to ensure proper localization of KIF4A to the mitotic machinery. Interacts with CCDC117; the interaction is direct.
Subcellular location. Nucleus. Cytoplasm. Cytoskeleton. Spindle. Midbody.
Similarity. Belongs to the MIP18 family.
RefSeq proteins (1): NP_057146* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002744 | MIP18-like | Domain |
| IPR034904 | FSCA_dom_sf | Homologous_superfamily |
| IPR039796 | MIP18 | Family |
Pfam: PF01883
UniProt features (2 total): initiator methionine 1, chain 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y3D0-F1 | 85.56 | 0.49 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Essential proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): cytosol; nucleoplasm
Antibody reliability (HPA): IH supported · IF supported
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 2; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
2 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-2564830 | Cytosolic iron-sulfur cluster assembly | electronic |
| R-HSA-1430728 | Metabolism | — |
MSigDB gene sets: 99 (showing top):
chr16q22, GOBP_PROTEIN_MATURATION, IRF1_Q6, ELK1_01, MCCLUNG_COCAIN_REWARD_4WK, GOCC_SPINDLE, GOCC_MIDBODY, GOBP_CELL_CYCLE_PROCESS, SCGGAAGY_ELK1_02, MULLIGHAN_MLL_SIGNATURE_1_UP, MGGAAGTG_GABP_B, IRITANI_MAD1_TARGETS_UP, GOBP_CHROMOSOME_SEGREGATION, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17, FORTSCHEGGER_PHF8_TARGETS_DN
GO Biological Process (3): chromosome segregation (GO:0007059), iron-sulfur cluster assembly (GO:0016226), protein maturation (GO:0051604)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), spindle (GO:0005819), cytosol (GO:0005829), midbody (GO:0030496), MMXD complex (GO:0071817), cytosolic [4Fe-4S] assembly targeting complex (GO:0097361)
Reactome top-level categories
1 top-level categories:
| Category | Pathways |
|---|---|
| Metabolism | 1 |
GO top-level categories
16 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cell cycle process | 1 |
| metallo-sulfur cluster assembly | 1 |
| gene expression | 1 |
| protein metabolic process | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| microtubule cytoskeleton | 1 |
| intracellular membraneless organelle | 1 |
| cytoplasm | 1 |
| spindle | 1 |
| protein-containing complex | 1 |
| intracellular protein-containing complex | 1 |
| iron-sulfur cluster assembly complex | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 9 of 12 annotations. The rest are phylogenetic / computational / electronic (IEA).
9 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| chromosome segregation | BP | mutant phenotype |
| protein maturation | BP | mutant phenotype |
| MMXD complex | CC | direct assay |
| cytoplasm | CC | direct assay |
| cytosol | CC | direct assay |
| cytosolic [4Fe-4S] assembly targeting complex | CC | direct assay |
| nucleoplasm | CC | direct assay |
| nucleus | CC | direct assay |
| spindle | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 1,376 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CIAO2B | MMS19 | Q96T76 | 861 |
| CIAO2B | CIAO1 | O76071 | 843 |
| CIAO2B | CIAO3 | Q9H6Q4 | 747 |
| CIAO2B | NUBP1 | P53384 | 720 |
| CIAO2B | CIAPIN1 | Q6FI81 | 713 |
| CIAO2B | NDOR1 | Q9UHB4 | 658 |
| CIAO2B | ERCC2 | P18074 | 593 |
| CIAO2B | ABCB7 | O75027 | 556 |
| CIAO2B | GLRX3 | O76003 | 536 |
| CIAO2B | ISCU | Q9H1K1 | 518 |
| CIAO2B | NFS1 | Q9Y697 | 499 |
| CIAO2B | ISCA1 | Q9BUE6 | 498 |
| CIAO2B | HSCB | Q8IWL3 | 496 |
| CIAO2B | FBXL5 | Q9UKA1 | 488 |
| CIAO2B | POLD1 | P28340 | 462 |
IntAct
Human interaction partners of CIAO2B in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
showing 30 of 31 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| CIAO1 | physical association | 0.950 | 22 |
| MMS19 | physical association | 0.830 | 4 |
| ERCC2 | direct interaction | 0.590 | 1 |
| CASP6 | physical association | 0.560 | 3 |
| CCK | physical association | 0.560 | 3 |
| FGFR3 | physical association | 0.560 | 3 |
| GRIN2C | physical association | 0.560 | 3 |
| GRN | physical association | 0.560 | 3 |
| GSN | physical association | 0.560 | 3 |
| HSPB1 | physical association | 0.560 | 3 |
| KIF1B | physical association | 0.560 | 3 |
| LAMP2 | physical association | 0.560 | 3 |
| PECAM1 | physical association | 0.560 | 3 |
| PRPF40A | physical association | 0.560 | 3 |
| PRPS1 | physical association | 0.560 | 3 |
| RAB5A | physical association | 0.560 | 3 |
| RAN | physical association | 0.560 | 3 |
| TTR | physical association | 0.560 | 3 |
| UBE2K | physical association | 0.560 | 3 |
| VIM | physical association | 0.560 | 3 |
| WFS1 | physical association | 0.560 | 3 |
| BRIP1 | direct interaction | 0.440 | 1 |
| LRRC59 | physical association | 0.400 | 1 |
| E6 | physical association | 0.370 | 3 |
| PB2 | physical association | 0.370 | 1 |
| ZNF16 | physical association | 0.370 | 1 |
| ELP1 | association | 0.350 | 1 |
| DSCAM | physical association | 0.000 | 1 |
| MLF2 | physical association | 0.000 | 1 |
| MTNR1A | physical association | 0.000 | 1 |
SIGNOR signaling
1 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| CIAO2B | “form complex” | “CIAO2B cytosolic iron-sulfur protein assembly complex” | binding |
Protein complexes (CORUM) (4)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
4 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| MMXD complex | 5 | CIAO2B, ERCC2, MMS19, SLC25A5, CIAO1 |
| MMS19 complex | 4 | CIAO1, CIAO2B, CIAO3, MMS19 |
| CIAO1-CIAO2B-MMS19 complex | 3 | CIAO1, CIAO2B, MMS19 |
| MMS19-FAM96B complex | 2 | CIAO2B, MMS19 |
Disease & clinical
Genetic variants
Variant evidence for CIAO2B: 35 ClinVar records (0 pathogenic / likely pathogenic).
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 1 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 31 predictions of 241):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 16:66933612–66933613 | donor_loss | 0.9900 | 5 |
| 16:66933740–66933741 | acceptor_loss | 0.9900 | 5 |
| 16:66933746 | acceptor_gain | 0.9900 | |
| 16:66932301–66932302 | acceptor_loss | 0.9800 | 6 |
| 16:66932317 | acceptor_gain | 0.9800 | |
| 16:66932826–66932827 | acceptor_loss | 0.9800 | 5 |
| 16:66933741 | acceptor_loss | 0.9800 | |
| 16:66933744 | acceptor_gain | 0.9800 | |
| 16:66932305 | acceptor_gain | 0.9700 | |
| 16:66932778–66932779 | donor_loss | 0.9700 | 5 |
AlphaMissense
648 missense substitutions predicted likely pathogenic (of 1,057 scored), across 124 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| M95 | 9 | 0.946 | 0.999 |
| D55 | 8 | 1.000 | 1.000 |
| D138 | 8 | 0.999 | 1.000 |
| H126 | 8 | 0.996 | 0.999 |
| H58 | 8 | 0.994 | 1.000 |
| N148 | 8 | 0.993 | 0.999 |
| N14 | 8 | 0.992 | 0.996 |
| D42 | 8 | 0.980 | 0.997 |
| H92 | 8 | 0.979 | 0.998 |
| F86 | 8 | 0.976 | 1.000 |
| D48 | 8 | 0.974 | 0.997 |
| S94 | 8 | 0.974 | 0.999 |
| N133 | 8 | 0.949 | 0.999 |
| D39 | 8 | 0.875 | 0.971 |
| F47 | 7 | 0.999 | 1.000 |
| C93 | 7 | 0.999 | 1.000 |
| E140 | 7 | 0.998 | 1.000 |
| E57 | 7 | 0.997 | 0.999 |
| E147 | 7 | 0.993 | 0.998 |
| F115 | 7 | 0.989 | 0.998 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Disease associations
OMIM: gene MIM:614778 | disease phenotypes:
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4295989 (SINGLE PROTEIN)
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 3 |
| sodium arsenite | increases abundance, increases expression | 2 |
| Rotenone | increases expression, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenate | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| cobaltous chloride | decreases expression | 1 |
| pyrimidifen | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Vitamin E | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4118721 | Binding | Binding affinity to FAM96B in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay | Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. — *Bioorg Med Chem* |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.